Dollé M E, Martus H J, Gossen J A, Boerrigter M E, Vijg J
Department of Medicine, Beth Israel Hospital, Boston, MA, USA.
Mutagenesis. 1996 Jan;11(1):111-8. doi: 10.1093/mutage/11.1.111.
To study in vivo somatic mutations a C57BL/6 transgenic mouse model was constructed harboring multiple chromosomally integrated copies of the plasmid pUR288, which carried the lacZ reporter gene as the mutational target. We previously demonstrated that lacZ-containing plasmids could be rescued from their integrated state efficient enough to detect mutations in lacZ by positive selection. The smaller size of the plasmid vector, as compared with our earlier transgenic mouse model based on bacteriophage lambda vectors, should offer considerable advantages in terms of rescue efficiency and sensitivity to large size alterations in the lacZ gene. To evaluate the plasmid-based mouse model for its suitability to detect in vivo mutations, we determined mutant frequencies in different organs of untreated and ethyl nitrosourea (ENU)-treated animals using a new, improved protocol. The rescue efficiencies obtained were as high as 200,000/micrograms genomic DNA; millions of transformants could be obtained in one single experiment. The average spontaneous mutant frequency in four different organs of 4- to 8-week-old mice ranged from 4.41 to 6.82 x 10(-5), compared with a mutant frequency of the same plasmid grown in Escherichia coli of approximately 1 x 10(-5) or less. Single treatments with 100 and 250 mg ENU/kg body wt resulted in a 7- and 14-fold increase, respectively, in spleen mutant frequency at 14 days after i.p. administration of the alkylating agent. Restriction enzyme analysis showed that a considerable portion of spontaneous mutants were size changes varying from approximately 100 to 3000 bp. Some mutant plasmids contained mouse genomic sequences, which is indicative of large genetic rearrangement events involving the 3' flanking regions of the transgene cluster. Among the ENU-induced mutants, size changes comprised only a minor fraction of the total, which is in keeping with the known ENU mutation spectra in vitro and in vivo. The high rescue efficiency of this plasmid-based model, in combination with its sensitivity to a broad spectrum of mutations, including large deletions, makes it very suitable as a general in vivo mutagenicity test system.
为了研究体内体细胞突变,构建了一种C57BL/6转基因小鼠模型,该模型含有多个染色体整合的质粒pUR288拷贝,该质粒携带lacZ报告基因作为突变靶点。我们之前证明,含lacZ的质粒可以从其整合状态有效拯救出来,以便通过阳性选择检测lacZ中的突变。与我们早期基于噬菌体λ载体的转基因小鼠模型相比,质粒载体的较小尺寸在拯救效率和对lacZ基因大尺寸改变的敏感性方面应具有相当大的优势。为了评估基于质粒的小鼠模型检测体内突变的适用性,我们使用一种新的改进方案,测定了未处理和经乙基亚硝基脲(ENU)处理的动物不同器官中的突变频率。获得的拯救效率高达200,000/微克基因组DNA;在一次实验中可以获得数百万个转化体。4至8周龄小鼠的四个不同器官中的平均自发突变频率范围为4.41至6.82×10⁻⁵,而同一质粒在大肠杆菌中生长的突变频率约为1×10⁻⁵或更低。腹腔注射烷化剂后14天,分别用100和250mg ENU/kg体重单次处理,脾脏突变频率分别增加了7倍和14倍。限制性酶切分析表明,相当一部分自发突变体是大小从约100至3000bp不等的变化。一些突变质粒包含小鼠基因组序列,这表明涉及转基因簇3'侧翼区域的大型基因重排事件。在ENU诱导的突变体中,大小变化仅占总数的一小部分,这与体外和体内已知的ENU突变谱一致。这种基于质粒的模型的高拯救效率,及其对包括大缺失在内的广泛突变谱的敏感性,使其非常适合作为一种通用的体内致突变性测试系统。